Looking Sick, page-6

The way forward

1.      Directors and the CEO need to start buyingshares on market at these very low prices. They need to prove to us that thecurrent price is a bargain, which it is in my opinion, the stock is currently apenny dreadful at a 3 year low. Not since October 2015 have we seen the shareprice this low. Even though directors participated in the capital raises of April2018 at 0.15, in July 2017 at 0.26 and in January 2017 at 0.31.  Now is the time to put a ceiling under theprice and buy on market.
The new directors took a position on the board, nowtake a position in the company.  TheCEO should be buying as well IMHO, what a steal 0.07c

 

2.      The market sees the lack of information as anegative, the company went from one extreme to another, firstly detailing theirObjectives in each presentation and meeting no objectives, then secondlypromising nothing and achieving nothing. Neither tactic has worked for them, beupfront and honest.  Where is the vision?what is the vision? Tell your shareholders about it. What’s next? what will bethe next newest technological advance. What is everyone working on, it justcan’t be modules for APAS. What is next after the MRSA module, Tell us.  Even In silly CEO speak… put some colouraround it.

 

3.      Get some sales done now.

 

4.      Get a microbiologist on the board.

5.       Do quarterly investor calls only if you have something to say, I listened to it last week and thought.......what was the point

 

In 2013 Clever Culture Systems was formed initially from 6Million invested by Hettich.

Since then I would suggest that close to 30 Million has beeninvested in bringing this technology to market, IMHO only, but here we are witha Market Capitalization of 14 Million.